KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Assets (2016 - 2025)

Pfizer (PFE) has disclosed Current Assets for 17 consecutive years, with $42.9 billion as the latest value for Q4 2025.

  • Quarterly Current Assets fell 14.81% to $42.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.9 billion through Dec 2025, down 14.81% year-over-year, with the annual reading at $42.9 billion for FY2025, 14.81% down from the prior year.
  • Current Assets for Q4 2025 was $42.9 billion at Pfizer, down from $46.9 billion in the prior quarter.
  • The five-year high for Current Assets was $74.0 billion in Q4 2023, with the low at $5.9 billion in Q4 2022.
  • Average Current Assets over 5 years is $46.4 billion, with a median of $46.4 billion recorded in 2025.
  • The sharpest move saw Current Assets surged 1147.67% in 2023, then crashed 48.43% in 2024.
  • Over 5 years, Current Assets stood at $59.7 billion in 2021, then dropped by 14.13% to $51.3 billion in 2022, then decreased by 15.46% to $43.3 billion in 2023, then rose by 16.21% to $50.4 billion in 2024, then dropped by 14.81% to $42.9 billion in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $42.9 billion, $46.9 billion, and $43.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.